About
RespirAI Medical is developing a wearable disease-management platform for home monitoring. The companys technology enables patients to manage multiple health conditions, improving their quality of life and reducing costs to the healthcare system. The system enables changes in patient health to be detected at an early stage, before the patient reports symptoms or experiences physiological decline. RespirAIs easy-to-wear passive sensing technology captures medical-grade physiological data a few minutes a day for long-term patient monitoring. Deviations from the patients clinical baselines are automatically synced to the cloud for analysis using advanced algorithms and artificial intelligence capabilities, and the results are shared with the patients care team and family. The systems core technology is based on an invention of researchers from the University of Nebraska at Omaha.
Funding history · 2 rounds · $1.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is RespirAI Medical's primary focus?
- RespirAI Medical is developing a wearable disease-management platform for home monitoring, enabling patients to manage multiple health conditions and detect changes at an early stage.
- When was RespirAI Medical founded?
- RespirAI Medical was founded in October 2020.
- What is the current employee count for RespirAI Medical?
- RespirAI Medical currently has 9 employees.
- What is the total amount of funding RespirAI Medical has raised to date?
- RespirAI Medical has raised a total of $1,000,000 USD.
- When did RespirAI Medical secure its Pre-Seed funding round and who was a lead investor?
- RespirAI Medical secured a Pre-Seed funding round in January 2022, with eHealth Ventures as a lead investor.
- What is the origin of RespirAI Medical's core technology?
- RespirAI Medical's core technology is based on an invention by researchers from the University of Nebraska at Omaha.
- Has RespirAI Medical received any grants from the IIA?
- Yes, RespirAI Medical has received grants from the IIA in January 2021, April 2024, and January 2025.
- What is a recent news highlight for RespirAI Medical regarding COPD?
- In August 2024, Israel21c reported that COPD flare-ups could be predicted via smartwatch using RespirAI Medical's technology.